The Role of Optical Coherence Tomography in Coronary Intervention

Optical coherence tomography (OCT) is an optical analog of intravascular ultrasound (IVUS) that can be used to examine the coronary arteries and has 10-fold higher resolution than IVUS. Based on polarization properties, OCT can differentiate tissue characteristics (fibrous, calcified, or lipid-rich plaque) and identify thin-cap fibroatheroma. Because of the strong attenuation of light by blood, OCT systems required the removal of blood during OCT examinations. A recently developed frequency-domain OCT system has a faster frame rate and pullback speed, making the OCT procedure more user-friendly and not requiring proximal balloon occlusion. During percutaneous coronary intervention (PCI), OCT can provide detailed information (dissection, tissue prolapse, thrombi, and incomplete stent apposition [ISA]). At follow-up examinations after stent implantation, stent strut coverage and ISA can be assessed. Several OCT studies have demonstrated delayed neointimal coverage following drug-eluting stent (DES) implantation vs. bare metal stent (BMS) placement. While newer DESs promote more favorable vascular healing, the clinical implications remain unknown. Recent OCT studies have provided insights into restenotic tissue characteristics; DES restenotic morphologies differ from those with BMSs. OCT is a novel, promising imaging modality; with more in-depth assessments of its use, it may impact clinical outcomes in patients with symptomatic coronary artery disease.

[1]  K. Hirata,et al.  The ability of optical coherence tomography to monitor percutaneous coronary intervention: detailed comparison with intravascular ultrasound. , 2010, The Journal of invasive cardiology.

[2]  R. Virmani,et al.  Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[3]  Eiji Toyota,et al.  Visualization of neointima formation by optical coherence tomography. , 2005, International heart journal.

[4]  Takahiko Suzuki,et al.  Accuracy and reproducibility of stent-strut thickness determined by optical coherence tomography. , 2009, The Journal of invasive cardiology.

[5]  Hiram G Bezerra,et al.  Angiographic, IVUS and OCT evaluation of the long-term impact of coronary disease severity at the site of overlapping drug-eluting and bare metal stents: a substudy of the ODESSA trial , 2010, Heart.

[6]  P. Serruys,et al.  Tissue coverage of a hydrophilic polymer-coated zotarolimus-eluting stent vs. a fluoropolymer-coated everolimus-eluting stent at 13-month follow-up: an optical coherence tomography substudy from the RESOLUTE All Comers trial , 2011, European heart journal.

[7]  Y. Jang,et al.  Mini-Focus Issue: Second-Generation DESEvaluation in 3 Months Duration of Neointimal Coverage After Zotarolimus-Eluting Stent Implantation by Optical Coherence Tomography: The ENDEAVOR OCT Trial , 2009 .

[8]  Eloisa Arbustini,et al.  Sources of error and interpretation of plaque morphology by optical coherence tomography. , 2006, The American journal of cardiology.

[9]  Y. Neishi,et al.  Measurement of the thickness of the fibrous cap by optical coherence tomography. , 2006, American heart journal.

[10]  Hiromasa Otake,et al.  Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography. , 2007, European heart journal.

[11]  Takahiko Suzuki,et al.  Safety and feasibility of an intravascular optical coherence tomography image wire system in the clinical setting. , 2008, The American journal of cardiology.

[12]  F. Prati,et al.  Safety and feasibility of frequency domain optical coherence tomography to guide decision making in percutaneous coronary intervention. , 2010, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[13]  Francesco Prati,et al.  From bench to bedside: a novel technique of acquiring OCT images. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[14]  M. Kimura,et al.  Difference of Tissue Characteristics Between Early and Very Late Restenosis Lesions After Bare-Metal Stent Implantation: An Optical Coherence Tomography Study , 2011, Circulation. Cardiovascular interventions.

[15]  K. Hirata,et al.  Delayed neointimalization on sirolimus-eluting stents: 6-month and 12-month follow up by optical coherence tomography. , 2009, Circulation journal : official journal of the Japanese Circulation Society.

[16]  Hiroto Tsujioka,et al.  Head to head comparison between the conventional balloon occlusion method and the non-occlusion method for optical coherence tomography. , 2011, International journal of cardiology.

[17]  T. Kume,et al.  Optical coherence tomography evaluation of zotarolimus-eluting stents at 9-month follow-up: comparison with sirolimus-eluting stents , 2009, Heart.

[18]  Takashi Akasaka,et al.  Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. , 2007, Journal of the American College of Cardiology.

[19]  Gijs van Soest,et al.  Optical coherence tomography patterns of stent restenosis. , 2009, American heart journal.

[20]  Y. Jang,et al.  Favorable neointimal coverage in everolimus-eluting stent at 9 months after stent implantation: comparison with sirolimus-eluting stent using optical coherence tomography , 2010, The International Journal of Cardiovascular Imaging.

[21]  K. Hirata,et al.  Factors that influence measurements and accurate evaluation of stent apposition by optical coherence tomography. Assessment using a phantom model. , 2009, Circulation journal : official journal of the Japanese Circulation Society.

[22]  E. Halpern,et al.  Characterization of Human Atherosclerosis by Optical Coherence Tomography , 2002, Circulation.

[23]  Eiji Toyota,et al.  Assessment of coronary arterial thrombus by optical coherence tomography. , 2006, The American journal of cardiology.

[24]  G. Ripandelli,et al.  Optical coherence tomography. , 1998, Seminars in ophthalmology.

[25]  Ruslan Hlushchuk,et al.  Coronary optical frequency domain imaging (OFDI) for in vivo evaluation of stent healing: comparison with light and electron microscopy , 2010, European heart journal.

[26]  Giuseppe Biondi-Zoccai,et al.  Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents. , 2010, JACC. Cardiovascular interventions.

[27]  Eiji Toyota,et al.  Assessment of coronary arterial plaque by optical coherence tomography. , 2006, The American journal of cardiology.

[28]  Nicusor Iftimia,et al.  Focal and multi-focal plaque macrophage distributions in patients with acute and stable presentations of coronary artery disease. , 2004, Journal of the American College of Cardiology.

[29]  Gary S. Mintz,et al.  Strut Coverage and Late Malapposition With Paclitaxel-Eluting Stents Compared With Bare Metal Stents in Acute Myocardial Infarction: Optical Coherence Tomography Substudy of the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial , 2011, Circulation.

[30]  Neointimal coverage on drug-eluting stent struts crossing side-branch vessels using optical coherence tomography. , 2010, The American journal of cardiology.

[31]  Hiroto Tsujioka,et al.  Advantage of next‐generation frequency‐domain optical coherence tomography compared with conventional time‐domain system in the assessment of coronary lesion , 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[32]  K. Seung,et al.  Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound. , 2002, Journal of the American College of Cardiology.

[33]  Masanori Yamamoto,et al.  Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation. , 2007, The American journal of cardiology.

[34]  Giulio Guagliumi,et al.  Optical coherence tomography: High resolution intravascular imaging to evaluate vascular healing after coronary stenting , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[35]  Brett E. Bouma,et al.  In Vivo Characterization of Coronary Atherosclerotic Plaque by Use of Optical Coherence Tomography , 2005, Circulation.

[36]  E Regar,et al.  Optical coherence tomography assessment of the acute effects of stent implantation on the vessel wall: a systematic quantitative approach , 2009, Heart.

[37]  P. Serruys,et al.  Delayed coverage in malapposed and side-branch struts with respect to well-apposed struts in drug-eluting stents: in vivo assessment with optical coherence tomography. , 2011, Circulation.

[38]  Takahiko Suzuki,et al.  Different patterns of vascular response between patients with or without diabetes mellitus after drug-eluting stent implantation: optical coherence tomographic analysis. , 2010, JACC. Cardiovascular interventions.

[39]  Takashi Akasaka,et al.  Comparison of vascular response after sirolimus-eluting stent implantation between patients with unstable and stable angina pectoris: a serial optical coherence tomography study. , 2008, JACC. Cardiovascular imaging.

[40]  Joseph M Schmitt,et al.  Current and future developments in intracoronary optical coherence tomography imaging. , 2009, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.